Home Page

Accugenix Genotypic Identification

Maximum accuracy.  Minimum hassle.

Rapid results... in as little as 7 hours


Comparative DNA sequencing of the 16S rRNA gene in bacteria and the ITS region for fungi has been proven to be the most accurate and reproducible method for identifying unknown organisms. Our Genotypic ID methods are widely accepted as the industry "gold standard" for the identification of bacteria, molds and yeasts. Techniques are independent of the health or growth conditions of the isolate, so samples can be viable or nonviable cultures, or simply genomic DNA from your microbe. The DNA for each sample is extracted, amplified and sequenced. The sequence is then compared to the validated Accugenix libraries of known sequences—the industry’s most comprehensive and up-to-date databases for environmental isolates.

There's not much we haven't seen.

OK, in the constantly changing world of microbiology, no one can say that. However, we've tested and identified more microorganisms than any other company or service laboratory in the world – which has allowed us to develop and refine a validated proprietary library and method of interpretation unrivaled in the industry. And we are constantly updating our organism libraries so they reflect current taxonomies and classifications, and are relevant to real-world frequency of occurrence criteria.

In cases where a species level result is not possible, the sequence provides valuable phylogenetic information about the sample. Most importantly, the sequence is like a "name" for the isolate which can be used in tracking and trending at the species level. To take it one step further, whether the species has been identified or not, the relatedness of samples to previous or future isolates can be examined and tracked at the strain level through our Microbial Characterization services.

Make a smart investment

Partner with Accugenix and gain access to innovative genetic ID technology and our incomparable technical experience—all without the cost of capital investment, process validation, personnel training, and risk of non-compliance.

Our Process          Results Analysis